• >
  • >
  • >
  • >
  • >
Upload Avatar (500 x 500)
Wenbin Liu
Mayo Clinic College of Medicine
University of Science and Technology of China
Anhui
Language: Chinese, English
Contact
Hepatocellular Carcinoma Recurrence Metastasis Clinical Research Basic Research Liver Cancer Oncology Tumor Cancer Treatment Medical Research
Areas of Focus
  • Basic and clinical research on recurrence and metastasis of hepatocellular carcinoma
Work Experience
  • 2005/07–2006/11 - Anhui Provincial Hospital, Liver Surgery - Resident Physician
  • 2006/12–2012/11 - Anhui Provincial Hospital, Liver Surgery - Attending Physician
  • 2012/12–2023/10 - The First Affiliated Hospital of USTC, Liver Surgery - Associate Chief Physician
  • 2023/10–Present - The First Affiliated Hospital of USTC, Liver Surgery - Chief Physician
Academic Background & Achievements
  • 2002/09–2005/06 Master's in Surgery (General Surgery): Anhui Medical University
  • 2008/09–2011/06 Doctorate in Clinical Medicine: Tianjin Medical University
Publications
  • Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma., Liu W, Xie Z, Shen K, Jiang L, Liu C, Ge Y, Yu J, Jia W, Ma J, Chen H., 2023
  • Application Effect of ICG Fluorescence Real-Time Imaging Technology in Laparoscopic Hepatectomy., Chen H, Wang Y, Xie Z, Zhang L, Ge Y, Yu J, Zhang C, Jia W, Ma J, Liu W., 2022
  • Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway., Wang W, Shen XB, Huang DB, Jia W, Liu WB, He YF., 2019
  • Expression of LAMP3 and its correlation with clinicopathologic characteristics and prognosis in hepatocellular carcinoma., Gui Y, Liu WB, Chen H, Ma JL, Li JS., 2018
  • Knockdown of GTPBP4 inhibits cell growth and survival in human hepatocellular carcinoma and its prognostic significance., Liu WB, Jia WD, Ma JL, et al., 2017
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that AGP may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from AGP.
Submit

Thank you for your message!
We will contact you soon.